KOREA UNITED PHARM (033270) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, KOREA UNITED PHARM (033270) reported revenue of 288.8 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025288.8 billion KRW49.6 billion KRW38.3 billion KRW[source]
2024288.7 billion KRW56.3 billion KRW32.5 billion KRW[source]
2023278.9 billion KRW54.9 billion KRW48.3 billion KRW[source]
2022262.5 billion KRW48.2 billion KRW45.3 billion KRW[source]
2021221.0 billion KRW33.2 billion KRW28.6 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025519.5 billion KRW64.9 billion KRW454.6 billion KRW[source]
2024473.9 billion KRW67.7 billion KRW406.2 billion KRW[source]
2023468.9 billion KRW90.2 billion KRW378.7 billion KRW[source]
2022417.9 billion KRW80.0 billion KRW337.9 billion KRW[source]
2021380.0 billion KRW79.3 billion KRW300.7 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice